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Intragenic Cis and Trans Modiﬁcation of Genetic Susceptibility
in DYT1 Torsion Dystonia
Neil J. Risch, Susan B. Bressman, Geetha Senthil, and Laurie J. Ozelius
A GAG deletion in the DYT1 gene is a major cause of early-onset dystonia, but clinical disease expression occurs in only
30% of mutation carriers. To gain insight into genetic factors that may inﬂuence penetrance, we evaluated three DYT1
single-nucleotide polymorphisms, including D216H, a coding-sequence variation that moderates the effects of the DYT1
GAG deletion in cellular models. We tested DYT1 GAG-deletion carriers with ( ) and without ( ) clinicalnp 119 np 113
signs of dystonia and control individuals ( ) and found the frequency of the 216H allele to be increased in GAG-np 197
deletion carriers without dystonia and to be decreased in carriers with dystonia, compared with the control individuals.
Analysis of haplotypes demonstrated a highly protective effect of the H allele in trans with the GAG deletion; there was
also suggestive evidence that the D216 allele in cis is required for the disease to be penetrant. Our ﬁndings establish, for
the ﬁrst time, a clinically relevant gene modiﬁer of DYT1.
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Primary torsion dystonia (PTD [MIM #128100]) is a ge-
netically and clinically heterogeneous disorder, encom-
passing several clinical subtypes and six designated gene
loci (DYT1, DYT2, DYT4, DYT6, DYT7, andDYT13).1 Only
one of these genes, DYT1, mapping to chromosome 9q34,
has been identiﬁed.2 DYT1 is a major cause of childhood-
and adolescent-onset PTD, especially among Ashkenazi
Jews (AJs), in whom it accounts for 80%–90% of early-
onset cases.3,4 A single heterozygous and recurring mu-
tation in the encoded protein, torsinA, accounts for all
reported DYT1-associated PTD.5 The mutation is an in-
frame deletion of three nucleotides (GAG) in exon 5,
which results in the loss of a glutamic acid residue at po-
sition 302 or 303 in the 332-aa protein. This same mu-
tation has arisen independently in different families, al-
though among AJs, there is an associated haplotype of
alleles implicating a founder mutation.2,6
The clinical manifestations of the DYT1 GAG deletion
are broad, ranging from mild focal dystonia, usually af-
fecting an arm, to generalized dystonia involving limbs,
axial, and even cranial muscles.4,7 Penetrance is estimated
at only 30%; thus, most mutation carriers are clinically
normal, or at least not affected with overt signs of dys-
tonia.8,9 To date, no studies have shed light on factors that
may contribute to the markedly reduced penetrance and
variable expression of the DYT1 GAG deletion. More pro-
gress has been made in the understanding of torsinA and
the effects of the DYT1 GAG deletion. Several lines of
evidence derived from both cellular and animal models
suggest roles for torsinA in regulating nuclear envelope
and endoplasmic reticulum (ER) organization.10,11,12 It is
postulated that the GAG deletion results in a distortion
in torsinA structure13; this structural change may then
underlie the mutant’s tendency to produce ER-derived
inclusions in cell culture11,14 and its proposed loss of
function.12,15
Aside from the GAG deletion, three other variations in
torsinA have been found that change the amino acid se-
quence: an 18-bp deletion,16 a 4-bp deletion,5 and a SNP
in the coding sequence for residue 216 that encodes as-
partic acid (D) in 88% and histidine (H) in 12% of control-
population alleles.2,16 In addition, a synonymous poly-
morphic coding-sequence change (A82A) and several SNPs
in the 5′ and 3′ UTR regions, as well as a single-base-pair
deletion in the 3′ UTR (G-del), have been noted. None has
been unequivocally associated with disease, although sev-
eral SNPs in the 3′ UTR have been associated with focal
dystonias.17,18 A recent study, however, has demonstrated
functional signiﬁcance of the D216H SNP. Cells overex-
pressing torsinA with the H allele developed inclusions
similar to those observed in cells overexpressing GAG-
deleted torsinA. Further, coexpression of both 216H- and
GAG-deleted torsinA reduced its tendency to form inclu-
sions, implying the two changes together have a canceling
effect.13 These ﬁndings suggest that the D216H polymor-
phism may have a role in human dystonia, possibly in-
ﬂuencing susceptibility to non-DYT1 dystonia and mod-
ifying penetrance of DYT1 dystonia.
To assess the possibility that the D216H as well as other
SNPs in the DYT1 gene inﬂuence penetrance, we inves-
tigated families with the DYT1 gene, reported elsewhere,
comparing family members with the GAG deletion who
have dystonia (i.e., “manifesting” carriers, or MC) with
family members with the deletion but without dystonia
(i.e., nonmanifesting carriers, or NMC). For example, if
the 216H variant reduces the pathogenicity of the GAG
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Figure 1. Schematic representation of the DYT1 gene showing
the position of the GAG-deletion mutation and the SNPs examined
in the study.
deletion, we would expect the frequency of the 216H allele
to be decreased in the MC and increased in the NMC.
In our analyses, we speciﬁcally looked for both trans
and cis effects. For a cis effect, we examined the chro-
mosomes carrying the GAG deletion in each family. Thus,
each independent family contributed one chromosome
(and hence one allele for each SNP) to the analysis. To
assure independence of the GAG deletion–bearing chro-
mosomes across families, we examined haplotypes on the
basis of microsatellite markers in each family, to iden-
tify GAG-bearing chromosomes with a unique origin. To
search for trans effects, we examined alleles for each poly-
morphism on the chromosomes without the GAG dele-
tion in mutation carriers. These alleles are inherited from
the parent not carrying the GAG deletion.
DYT1 and control subjects.—Subjects were recruited from
families participating in previous genetic studies of dys-
tonia and were included in the present study if they were
found to harbor the DYT1 GAG deletion.9,19 Control sam-
ples included unrelated noncarriers from DYT1-affected
families, as well as AJ parents from dysautonomic families
and CEPH controls. The study was approved by institu-
tional review boards, and all subjects gave informed con-
sent to participate. The methods for recruitment, ethnic
determination, and diagnosis have been described else-
where.9,19,20 For analysis of trans effects, we included 148
AJ subjects with the GAG deletion (75 MC and 73 NMC)
from 100 nuclear families and 104 AJ controls, as well as
84 non-Jewish (NJ) subjects with the GAG deletion (44
MC and 40 NMC) from 41 nuclear families and 93 NJ
controls. For both AJ and NJ, controls were unrelated in-
dividuals with no personal or family history of dystonia.
Molecular and statistical analyses.—DNA was extracted
from white-blood or buccal cells by use of the Purgene
procedure (Gentra Systems). Three SNPs in theDYT1 gene
were selected on the basis of functional signiﬁcance and
heterozygosity. These included a synonymous alaniner
alanine change at position 82 (A82A, rs2296793), a sub-
stitution of aspartic acid (D) for histidine (H) at position
216 (D216H, rs1801968), and a deletion of a single nu-
cleotide G in the 3′ UTR (G versus G for the normal
allele, rs3842225) (ﬁg. 1). The SNPs were ampliﬁed by PCR
with primers and conditions listed in table 1. The primers
used for ampliﬁcation and sequencing were designed us-
ing PSQ version 1.0.6 software (Biotage). Each ampliﬁca-
tion set contained a biotin-labeled primer. SNPgenotyping
was performed using a Pyrosequencing PSQ HS 96A sys-
tem 1.2 (Biotage).
Five microsatellite markers spanning the DYT1 gene—
D9S159, D9S2160, D9S2161, D9S63, and D9S2162—were
ampliﬁed using primers and conditions reported else-
where.21 All primer sets contain a ﬂuorescent tag at the 5′
end of the sense primer. The ampliﬁed PCR products were
resolved on the ABI 3730 automated DNA sequencer, and
the results were analyzed using the GeneMapper 3.5 soft-
ware (Applied Biosystems).
For the statistical analysis of trans effects, we compared
allele frequencies or haplotype frequencies between MC
andNMCon chromosomes inherited from theparentwith-
out the GAG deletion. Haplotypes were determined by
family inheritance. We included all carriers in our anal-
yses, including multiple siblings from the same nuclear
family. The allele frequencies in such individuals are not
independent, because of shared parentage. We adjusted
for this relatedness in our analyses, as described below.
Speciﬁcally, among the AJ families, therewere 62 singleton
carriers, 30 sibships with 2 carriers, 6 sibships with 3 car-
riers, and 2 sibships with 4 carriers. Among NJ families,
there were 19 singleton carriers, 10 sibships with 2 carriers,
7 sibships with 3 carriers, 3 sibships with 4 carriers, and
2 sibships with 6 carriers.
Siblings are correlated in their allele frequencies because
of shared inheritance from the non-GAG parent, whereas
individuals from different sibships within the same pedi-
gree are uncorrelated because they have inherited their
non-GAG chromosome from unrelated individuals. To as-
sess statistical signiﬁcance, allele frequencies were com-
pared between the MC and NMC. However, instead of
doing a standard x2 test treating everyone as independent,
we allowed for the correlation of siblings in the analysis
and adjusted the variance of the difference accordingly.
Speciﬁcally, let p′ be the observed allele (or haplotype)
frequency in n MCs and q′ be the frequency in m NMCs.
Let . Our statistic is based on , where′ ′ 2Tp p  q T /Var (T)
Var(T) is the estimated variance of T. Because, in the cal-
culation of T, affected siblings from the same family are
positively correlated and unaffected siblings from the same
family are also positively correlated, we need to add ad-
ditional covariance terms in the variance formula for T
because of these pairs. By contrast, affected-unaffectedcar-
rier sib pairs from the same family induce a negative cor-
relation contributing to Var(T); thus, we need to subtract
additional covariance terms for the variance of T for these
pairs. Speciﬁcally, for the variance of T, we employ the
formula
1 1 I J K′ ′Var (T)p pq     ,( )2 2m n 2n 2m 2mn
where I is the number of concordant affected carrier sib
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Table 1. SNPs Genotyped in the DYT1 Gene
SNP
Gene
Position
DNA
Change
Amino
Acid
Change
Primer Sequence
(5′r3′) Fragment
Size
(bp)
PCR
Temperature
(C)
Mg2
(mM)Forward Reverse Pyrosequencing
rs2296793 Exon 2 ArG A82A CGAAATTTTTGCCGGTGCC GACGGCTTTGCTGGCTTTCTTATa TTGTTTATGAAACCAAACAC 244 62 1.5
rs1801968 Exon 4 CrG D216H AACCCTGTCCTTACCCACTGa TCTGCTTTCCACTCCTCCAG GAAATCCAAAGCCACA 97 57 2.5
rs3842225 3′ UTR G-del AACTTGTCACTTGCCAGTCACTCCa GAATCCAGCAGAGAGCACGTGT AGAGAGCACGTGTGG 89 62 1.5
a 5′ Biotinylated primer.
Table 2. DYT1 SNP and Haplotype Frequencies on
Non-GAG Chromosomes in MCs, NMCs, and Controls
Status
No. of
Chromosomes
SNP
Frequency Haplotype Frequency
216H G D216/G D216/G 216H/G
MC 119 .017 .227 .756 .227 .017
NMC 113 .212 .230 .558 .230 .212
NC 394 .144 .236 .619 .236 .144
pairs, J is the number of concordant unaffected carrier sib
pairs, and K is the number of discordant affected-unaf-
fected carrier pairs.
For all analyses, there were no differences between the
AJ and NJ samples in terms of allele or haplotype fre-
quencies; thus, all results are presented for these two
groups combined. We assumed an asymptotic x2 distri-
bution for .2T /Var (T)
Cis and Trans Frequencies of DYT1 SNPs in affected and
unaffected carriers of the GAG deletion.—We observed com-
plete linkage disequilibrium (LD) of the A82A SNP with
the G deletion polymorphism (G/G), so we considered
further only the deletion polymorphism, reducing the
analyses to two SNPs: the G-del and the D216H. These
two were also in LD but not complete LD. There were three
haplotypes that occurred with these two SNPs: D216/G,
D216/G, and 216H/G; the 216H/G haplotype did not
occur.
As can be observed in the analyses of non-GAG chro-
mosomes (table 2), the 216H allele was increased in fre-
quency in the NMC and was decreased in frequency in
the MC compared with the controls. The allele-frequency
difference between the NMC and MC is highly signiﬁcant
( ; ). By contrast, there was no dif-2x p 22.55 P ! .000002
ference in allele frequency for the G allele among the
MC, NMC, and NC groups.
In the analysis of haplotypes, the 216H/G haplotype
was increased in frequency, whereas the D216/G haplo-
type was decreased in frequency in the NMC versus MC.
The D216/G haplotype had similar frequency in the two
groups. This might suggest that the D216 allele in ciswith
G is more predisposing than when the D216 allele is in
cis with G. If the 3′ G deletion or another SNP that is in
LD with the G deletion leads to a reduction in expression
levels of the protein encoded in cis, then it could be that
having the G allele in cis with D216 is associated with
reduced expression levels of the D216 allele, leading to a
lower level of risk. However, there was not a statistically
signiﬁcant difference between the D216/G and D216/G
haplotype frequencies ( ; ). It is clear that2x p 1.02 P 1 .3
the principal effect is the large and opposite trend for the
D216/G and 216H/G haplotypes, both of which carry
the normal allele at G-del, suggesting that the primary
impact on risk is due to decreased susceptibility associated
with the 216H allele.
Table 3 provides the results of analyses of the GAG-
deletion chromosomes that were deemed to be indepen-
dently inherited on the basis of microsatellite haplotypes
and ethnic origins (i.e., those with distinct original foun-
ders). One chromosome was unphased and was hetero-
zygous and therefore could be 216H or D216. Of the re-
maining 21, all were D216. Five of these chromosomes
came from subjects whose ethnicity is other than white.
The D216 allele is the predominant allele in all popula-
tions, including East Asians (frequencyp.95), West Afri-
cans (frequencyp1.0), and Europeans (frequencyp.81)
(Gene Cards for TOR1A). However, using the frequency
of the D216 allele, in whites (.856), we found that, of 16
chromosomes, we would have expected .856# 16p 13.7
to carry the D216 allele and 2.3 to carry the 216H allele.
The probability of actually observing no 216H allele is
.083. This result is highly suggestive that, in addition to
the trans effect we observed above with the D216 allele,
there may also be a cis effect, in which the GAG deletion
needs to be carried in conjunction with the D allele to be
penetrant.
The 216H allele in trans protects against disease expres-
sion.—We found strong evidence indicating that the
D216H polymorphism modiﬁes clinical manifestation of
the DYT1 GAG deletion. We identiﬁed the H allele as
highly protective; only 2 of 119 affected carriers had the
216H allele, compared with 24 of 113 unaffected carriers.
This protective effect occurred in trans—that is, on chro-
mosomes inherited from the non-GAG parent. There was
also evidence, albeit less compelling, that the D allele in
cis with the GAG deletion is required for disease to be
penetrant.
The protective effect of the 216H allele is powerful.
However, its overall contribution to explaining reduced
penetrance is modest, because the H allele is uncommon
(maximum frequency of 19% in whites). To estimate the
allele-speciﬁc penetrances for the D216H polymorphism
in trans, we employ two approaches. Let A denote the
status of being affected and N denote unaffected. Let D
denote the state of carrying the D216 allele in trans,
whereas H denotes carrying the 216H allele in trans. Our
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Table 3. DYT1 D216H Allele Frequencies on
GAG-Deletion Chromosomes from Independent
Patients with PTD
Race/Ethnicity
No. of
Chromosomes
Allele
Distribution
White 17 16 D; 1 H or D
Asian 3 3 D
African American 1 1 D
Mexican 1 1 D
All 22 21 D; 1 H or D
ﬁrst estimates are based on the allele frequencies observed
in the MC and NMC groups (table 2). The penetrance
associated with carrying the D216 allele is determined by
P(DFA)P(A)
P(DFA)P(A) P(DFN)P(N)
(.983)(.30)
p p .348 ,
(.983)(.30) (.788)(.70)
where P denotes probability and the assumption is that
the overall penetrance P(A) for GAG-deletion carriers is
30%,8,19 P(DFA) is the frequency of the D216 allele in MC,
and P(DFN) is the frequency of the D216 allele in NMC.
Similarly, the penetrance associated with carrying the
216H allele is determined by
P(HFA)P(A)
P(HFA)P(A) P(HFN)P(N)
(.017)(.30)
p p .033 .
(.017)(.30) (.212)(.70)
Our second estimates are based on the allele frequencies
observed in the MC and NC groups (table 2). Here, the
formula for the penetrance associated with carrying the
D216 allele is
P(DFA)P(A) (.983)(.30)
p p .345 ,
P(D) .856
where P(D) is the frequency of the D216 allele in NC.
Similarly, the penetrance associated with carrying the 216H
allele is
P(HFA)P(A) (.017)(.30)
p p .035 ,
P(H) .144
where P(H) is the frequency of the 216H allele inNC. Thus,
the penetrance associated with carrying the D216 allele
in trans is ∼35%, and, for the 216H allele, it is ∼3%.
These estimates contrast with 30% penetrance when
there is no knowledge of this SNP. Thus, clinical appli-
cation of our ﬁnding in genetic counseling is important
but will have a signiﬁcant impact for only a minority of
subjects. It allows assessment of a much-reduced risk in
individuals who are 216H carriers and predicts a slightly
increased risk for the D216 carriers.
Althoughoriginally controversial, systematic familystud-
ies have demonstrated early-onset PTD to have a domi-
nantmode of inheritancewith reduced penetrance.8,19Our
ﬁnding of an intragenic SNP modiﬁer now alters that con-
clusion, at least to a minor extent. There is an intragenic
interaction between the GAG deletion and the D216H
polymorphism in creating risk of disease manifestation.
Mode of inheritance still appears dominant, because the
permissive D216 allele has high frequency (1.80). If, in
fact, the D216 allele were rare, the mode of inheritance
would likely appear more recessive, since both the GAG
deletion and the D216 allele would need to be inherited
for disease expression.
Reports of intragenic trans modiﬁcation in other dom-
inant human diseases are rare. One example is provided
by hereditary spastic paraplegia, which is due to spastin
gene mutations. In that disorder, although the major ef-
fect is due to mutations in the AAA domain of spastin,
other amino acid substitutions in the same gene impact
the severity of the disease, including age at onset.22
The results of the present clinical study are consistent
with overexpressing cellular models of GAG-deleted tor-
sinA, where a high frequency (80% of cells) of inclusions
is observed with coexpression of the D216 and lower fre-
quency (60%) is observed when combined with the 216H
allele.13 Further, like the GAG deletion, cells overexpress-
ing torsinA with the 216H allele form inclusions, although
to a lesser extent than those with the GAG deletion. The
reason for these effects is unclear, but the D216H poly-
morphism is predicted to be exposed on the surface of
assembled hexamers. Thus, itmay disrupt or alter hexamer
subunit-subunit interactions.13 Further delineation of these
interactions, including studies examining cis and trans ef-
fects, should help reﬁne understanding of this change.
We also present suggestive evidence that a deletion SNP
in the 3′ UTRmay have an inﬂuence onDYT1 penetrance,
although statistical signiﬁcance was lacking. However, it
is tempting to speculate that regulatory SNPs that occur
in ciswith either the GAG deletion or the D216 allele have
an inﬂuence on disease expression; variants decreasing the
expression of these alleles would be expected to reduce
penetrance, and such was the direction of our results. We
also note that, if this is the case, the 3′ UTR G deletion
may not be the functional variant, since this allele was in
complete LD with another synonymous SNP in the coding
region (A82A). Whereas the latter has no effect on the
amino acid sequence, it may still inﬂuence expression lev-
els of the protein in cells. Or, since the region containing
theDYT1 and TOR1B genes shows strong LD, another SNP
in this region could be functional.
Our study demonstrates the importance of studying
trans and cis effects of polymorphisms on disease genes in
the modiﬁcation of their penetrance or expression. Al-
though the 216H allele has a potent effect, it explains only
a small proportion of the reduced penetrance associated
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with carrying the DYT1 GAG-deletion mutation. Also, al-
most all manifesting carriers, regardless of severity, were
homozygous for the D216 allele, so factors moderating
the extent of disease expression in these individuals re-
main unknown. Additionally, the 216H polymorphism
and other DYT1 variants require additional study in dys-
tonias not due to the DYT1 GAG deletion. Indeed, there
is support for this approach; several studies have impli-
cated commonDYT1 haplotypes in adult focal (non-GAG)
dystonias,17,18,23 although two other reports failed to rep-
licate the ﬁndings.24,25 The D216H SNP was speciﬁcally
examined in two of the studies, and, in both cases, no
associations were identiﬁed,17,23 suggesting that other SNPs
in the DYT1 gene may play a role in focal dystonias.
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